Cellectar Biosciences, Inc. (CLRB)
3.16
+0.07
(+2.27%)
USD |
NASDAQ |
May 18, 16:00
3.16
0.00 (0.00%)
After-Hours: 16:58
Cellectar Biosciences Total Liabilities (Quarterly) : 6.403M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | 397.06M |
| Ocugen, Inc. | 51.10M |
| Invivyd, Inc. | 38.69M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.12M |
| Shareholders Equity (Quarterly) | 4.717M |
| Debt to Equity Ratio | 0.3241 |
| Current Ratio | 1.901 |
| Net Debt Paydown Yield | -1.92% |